marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2020
added 08-19-2023
Titan Medical Financial Ratios 2011-2024 | TMDI
Annual Financial Ratios Titan Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -4.7 | -0.4 | -0.9 | -2.1 | -2.5 | -2.3 | -10.1 | -12.1 | -10.3 | -5.2 |
P/S |
- | 5.7 | - | - | - | - | - | - | - | - | - |
EPS |
- | - | - | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
-20.4 M | 133 M | 29.6 M | 26.5 M | 65 M | 59.4 M | 109 M | 136 M | 111 M | 80.7 M | 84.5 M |
EBITDA per Share |
- | 0.06 | -1.93 | - | - | -5.69 | -12.3 | -4.7 | -3.77 | -3.61 | -8.73 |
EV/EBITDA |
0.7 | 32.6 | -0.2 | -1.6 | -2.9 | -2.1 | -2.2 | -9.2 | -12.4 | -10.3 | -4.6 |
PEG |
- | -0.1 | 1.02 | -0.04 | -0.23 | -0.04 | 0.01 | 0.95 | 1.75 | -0.17 | 0.02 |
P/B |
- | -8.3 | -1.3 | 4.8 | 7.4 | 96.1 | -233.2 | - | 54.2 | 17.1 | 9.0 |
P/CF |
- | -135.6 | -0.3 | -0.5 | -3.7 | -1.6 | -2.8 | -10.5 | -13.7 | -10.2 | -5.4 |
ROE % |
-42.10 | 175.14 | 358.74 | -536.84 | -349.62 | -3922.55 | 10069.61 | - | -449.01 | -166.52 | -172.61 |
ROA % |
-31.46 | -81.05 | -1239.27 | -103.30 | -113.18 | -324.28 | -321.37 | - | -282.55 | -134.49 | -142.09 |
ROCE % |
-87.80 | -31.79 | 507.68 | - | - | -4676.19 | 10369.05 | - | -451.98 | -168.45 | -173.63 |
Current Ratio |
4.0 | 0.7 | 0.2 | 1.2 | 1.5 | 1.0 | 0.9 | - | 2.5 | 4.7 | 5.4 |
DSO |
- | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Titan Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | - | -0.06 | 0.12 | - | - | -0.58 | -0.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-69.16 | -102.78 | -101.82 | -104.74 | -86.93 | -131.06 | -141.56 | -193.46 | -89.79 | -4.12 | 125.67 | 259.46 | 164.64 | 227.29 | 204.29 | 205.09 | 142.44 | 142.44 | 79.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-51.91 | -68.99 | -60.12 | -61.68 | -43.79 | -49.62 | -38.36 | -40.33 | -9.36 | -262.05 | -508.93 | -573.62 | -320.92 | -320.92 | -68.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-90.89 | -146.42 | -156.50 | -162.77 | -101.83 | -223.48 | -289.60 | 74.23 | 256.54 | 365.87 | 596.84 | 354.72 | 224.76 | 224.76 | 115.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 4.0 | 4.0 | 2.0 | 2.1 | 2.0 | 0.7 | 1.1 | 1.1 | - | 0.2 | 0.2 | 0.5 | - | 1.2 | - | - | - | 1.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency